Description
DESCRIPTION (provided by applicant): Sickle cell disease (SCD) is characterized by acute clinical manifestations, including painful crisis, acute chest syndrome, priapism, and stroke, as well as chronic irreversible damage to the heart, lungs, kidneys, eyes, spleen and femoral heads. Vascular injury and occlusion, primarily affecting the microvasculature, underlie most of these complications. Another characteristic of sickle cell patients, both adult and pediatric, is a high prevalence of low vitamin B6 status (exceeding 50%), as indicated by low plasma pyridoxal-5'- phosphate levels (
| Status | Finished |
|---|---|
| Effective start/end date | 4/15/07 → 3/31/12 |
Funding
- National Institutes of Health: $363,197.00
- National Institutes of Health: $363,470.00
- National Institutes of Health: $363,470.00
- National Institutes of Health: $363,470.00
Fingerprint
Acute Chest Syndrome
Priapism
Vitamin B 6
Pyridoxal Phosphate
Vascular System Injuries
Sickle Cell Anemia
Thigh
Microvessels
Blood Vessels
Spleen
Stroke
Pediatrics
Kidney
Lung
ASJC
- Medicine(all)